Lucence Presents Real-World Evidence on Applications of Liquid Biopsy at 2021 ASCO, Announces Formation of Medical Advisory Board

Excerpt from the Press Release:

PALO ALTO, Calif.–(BUSINESS WIRE)–As part of the 2021 ASCO Annual Meeting, precision oncology company Lucence is sharing real-world data supporting clinical applications of its amplicon-based liquid biopsy assay. The data will be presented in on-demand virtual poster sessions, available beginning June 4 at 9 AM EDT.

Lucence is also announcing the formation of a medical advisory board in the United States. Lucence’s Medical Advisory Board will be tasked with providing strategic, patient-centered guidance on research, development, and clinical applications of amplicon-based liquid biopsy tests. Dr. Gilberto Lopes of the University of Miami will join as an advisor.

Gilberto de Lima Lopes Jr., MD, MBA, FAMS is Interim Chief for the Division of Medical Oncology, Medical Director for International Programs and Associate Director for Global Oncology at the Sylvester Comprehensive Cancer Center, and Professor of Clinical Medicine at the Miller School of Medicine at University of Miami. Dr. Lopes’ career spans North America, Latin America, and Asia, and he has dedicated much of his time to the issues of cancer control and access to medications in low- and middle-income countries. Dr. Lopes is the Editor-in-Chief of ASCO’s Journal of Global Oncology.

Click the button below to read the entire Press Release:

Continue Reading The Press Release